По запросу "" найдено страниц: 898

1. Главная
Дорогие друзья! С первых дней работы приоритетными направлениями деятельности предприятий входящих в состав группы компаний Фармстандарт являются р...

2. О компании


3. Company Structure
111

4. Product Portfolio


5. Company Profile
ПРОВЕРЯЕМ ПАО «Фармстандарт» — лидирующая фармацевтическая компания в России, занимающаяся разработкой и произво...

6. Phs-Leksredstva JSC
Phs-Leksredstva JSC Company Profile Address: 1a/18, 2-ya Agregatnaya street, Kursk, Kursk Region, 305022 Phone: +7 (4712) ...

7. Pharmstandard-UfaVITA JSC
Pharmstandard-UfaVITA JSC Company Profile Contact information: Address: 28, Khudayberdina str., Ufa, Republic of Bashkortostan, 450...

8. PHS-Tomskhimpharm JSC
PHS-Tomskhimpharm JSC Company Profile Address: 211, Prospekt Lenina, Tomsk, Tomsk Region, 634009 Telephone/fax: (382-2) 40-28-56 ...

9. Quality Standards
Quality Standards All Pharmstandard operating companies have a functional and constantly improving quality management system. The Group commi...

10. Corporate
Governance


11. Documents


12. Press Releases


13. Annual Reports
Annual report 2015 Annual report 2014 Annual report 2013 Annual report 2012 Annual report 2011 Annual r...

14. Product Portfolio


15. Research findings


16. Safety Control
Мониторинг безопасности препаратов компании Компания Фармстандарт заботится о безопасности своих препаратов и здоровье потребителей. Следуя этическим...

17. Quality Management
123

18. Company annual reports
Annual report 2016 Annual report 2015 Annual report 2014 Annual report 2013 ...

19. Newsroom


20. Contacts us
Адрес: 141701, Московская область, г. Долгопрудный, Лихачевский проезд, дом 5Б Телефон/Факс: (495) 970–0030/32 Корпоративным транспорто...

21. Our News


22. Media about us


23. Chart


24. Historical quotes
 

25. Investment calculator
 

26. Photo & Video Gallery


27. Врачам
.

28. Manufacturing Capabilities


29. Annual financial statements


30. Scheduled Events


31. Часто задаваемые вопросы


32. Результаты выкупа акций
Список акционеров Компании, имевших право требовать Выкупа был сформирован на 5 июля 2013 года. Акционеры Компании, голосовавшие против принятия решен...

33. Регистрация ОАО «Отисифарм»
Москва, 16 декабря 2013 года - ОАО «Фармстандарт» (LSE: PHST LI, RTS: PHST RU) (далее «Компания» или «Фармстандарт»...

34. Дополнительная информация
Разделительный баланс ОАО "Фармстандарт   ...

35. Информация к ВОСА
ВОСА. Внеочередное общее собрание акционеров (далее «ВОСА») ОАО «Фармстандарт» (далее «Компания») по рассмотрению ...

36. Pharmstandard JSC
Pharmstandard JSC Russia`s leading pharmaceutical company ensures development and distribution of advanced, high-quality and affordable medicines tha...

37. IFRS Financial Statements


38. About Powers of Attorney
Updated Information  This page is intended for posting the fact that any Power of Attorney issued by Pharmstandard Group is revoked. JSC &ldquo...

39. Pharmstandard LLC


40. Lekko CJSC
LEKKO CJSC Company Profile Address: Zavodskaya Street, Building 278, Volginsky settlement, Petushinsky District, Vladimir Regio...

41. J.S.C. “Biomed”- Mechnikov
J.S.C. “Biomed”- Mechnikov Company Profile Address: Petrovo-Dalnee settlement, Krasnogorsky District, Moscow Region, 143...

42. Term of use
Terms of Use All content of this Internet site is owned by JSC Pharmstandard and is protected by applicable laws. You may us...

43. Compliance


44. Business partners
тес т

45. Our Factories
Компания владеет несколькими производственными предприятиями, оснащенными новейшим оборудованием.Вид предприятий можно условно разделить нафармацевтич...

46. Areas of Cooperation


47. Development

131. Notice of 2011 Audited Financial Results and 1Q 2012 sales results – announcement date
Moscow, 23 April 2012 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 2011 audited Financial Results and 1Q 2012 S...

132. JSC Pharmstandard reports 2011 audited Financial Results and 1Q 2012 Sales Results
Moscow, 27 April, 2012 – JSC Pharmstandard (LSE: PHST IL, RTS: PHST RU) reports 2011 audited Financial Results in compliance with IFRS and 1Q 20...

133. PHARMSTANDARD to hold the AGM on 25 May 2012
Moscow, 6 April, 2012 – JSC Pharmstandard (LSE: PHST, RTS: PHST RU) invites its shareholders/holders to its annual general meeting of shareholde...

157. Notice of Q2/H1 2014 Sales Results – announcement date
Moscow, August  11, 2014 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its Q2/H1 2014  sales result...

158. Board of Directors statement with regards to the Tender Offer
Moscow, 28 May 2015 - Public Joint Stock Company "Pharmstandard" (LSE: PHST, RTS: PHST RU) (the "Company") announces the decision of its Board of Dire...

159. Change of conditions of the Tender Offer
Moscow, June 4, 2015 - Public Joint Stock Company "Pharmstandard" (LSE: PHST, RTS: PHST RU) (the "Company") announces that it has been informed by Aug...

160. The Board of Directors recommends to accept the Tender offer made by Augment Investments Limited
Moscow, June 15, 2015 - The Board of Directors of PJSC Pharmstandard (LSE: PHST, РТС: PHST RU) (the Company) decided: to acknowledge that the purchase...

161. The Board of Directors of PJSC Pharmstandard approved changes in the management structure
Moscow, June 18, 2015 - The Board of Directors of PJSC Pharmstandard (LSE: PHST, MOEX: PHST RU) (the Company) approved the segregation of functions of...

162. Augment notified Pharmstandard about the result of the Tender Offer
Moscow, June 23, 2015 - Public Joint Stock Company "Pharmstandard" (LSE: PHST, RTS: PHST RU) (the "Company") announces that it has been informed by Au...

163. Board of Directors approved recommendations in respect of the Mandatory tender offer and approved amendments to the Deposit Agreement
PJSC PHARMSTANDARD (LSE: PHST IL, МОЕХ: PHST RU) ANNOUNCES APPROVAL BY THE COMPANY’S BOARD OF DIRECTORS OF RECOMMENDATIONS IN RESPECT OF THEMAND...

164. Notice of 2010 Audited Financial Results and 1Q 2011 sales results – announcement date
Moscow, 22 April 2011 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 2010 audited Financial Results and 1Q 2011 S...

165. JSC Pharmstandard reports 2010 and 1Q2011 sales results
Moscow, 28 April, 2011 – JSC Pharmstandard (LSE: PHST IL, RTS: PHST RU) reportsits audited 2010 sales results, in compliance with IFRS and non-a...

166. PHARMSTANDARD to hold the AGM on 30 June 2011
Moscow, 11 May, 2011 — JSC Pharmstandard (LSE: PHST, RTS: PHST RU) invites its shareholders/holders to its annual general meeting of s...

167. ARBIDOL IS EFFECTIVE FOR PREVENTION “SWINE INFLUENZA”
Moscow, 29 April, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces that Arbidol® may be used for prevention and treatmen...

168. Pharmstandard Published 2008 Annual Report
Moscow, 30 April, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) issued Annual Report for the year 2008. Please use the following link t...

169. PHARMSTANDARD TO HOLD THE AGM ON 30 JUNE 2009
Moscow, 14 May, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) invites its shareholders/holders to its annual general meeting of sha...

170. Notice of 2009 sales results announcement date
Moscow, 10 February, 2010 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 2009 sales results on Thursday, 11 ...

171. Pharmstandard Reports 2009 Sales Results
Moscow, 11 February, 2010 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces its unaudited 2009 sales results. The total revenue of the ...

172. Pharmstandart becomes the first Russian IPEC Europe member
PHARMSTANDARD BECOMES THE FIRST RUSSIAN IPEC EUROPE MEMBER   Moscow, 01 July, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) ...

173. Notice of 1h2009 sales results announcement date
Moscow, 16 July, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 1H2009 sales results on Tuesday, 21...

174. Extraordinary General Meeting 2 September 2009
Moscow, 17 July, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) informs its shareholders/holders on carrying out of extraordinary ge...

175. Pharmstandard Reports 1H2009 Sales Results
Moscow, 21 July, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces its unaudited 1H2009 sales results. The total revenue...

176. NOTICE OF FIRST HALF 2009 UNAUDITED RESULTS ANNOUNCEMENT DATE
Moscow, 26 August 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its unaudited results for the first half 2009 on...

177. Results of Annual General Meeting
  RESULTS OF ANNUAL GENERAL MEETING   Moscow, 01 July, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces the r...

178. Pharmstandard Reports Unaudited 1H2009 IFRS Results
Moscow, 1 September, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces its unaudited 1H2009 IFRS results. Net profit of ...

179. JSC “Pharmstandard” convenes the Extraordinary General Meeting of Shareholders
Moscow, 03 September, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) declares the resolutions adopted by the Extraordinary General M...

180. Notice of 3Q2009 sales results announcement date
Moscow, 15 October, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 3Q2009 sales results on Monday, 19 Oc...

181. Pharmstandard Reports 9m2009 Sales Results
Moscow, 19 October, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces its unaudited IFRS sales results for the nine-month per...

182. OJSC Pharmstandard reports about acquisition of 11,3% ordinary shares of the leading Baltic pharmaceutical company JSC Grindex.
CEO of “Pharmstandard” Igor Krylov commented: «The decision to buy Grindex  shares is based on long-term history of fair deali...

183. Notice of 2009 Audited Financial Results and 1Q 2010 sales results – announcement date
Moscow, 26 April 2010 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 2009 audited Financial Results and 1Q 2010 S...

184. Pharmstandard Published 2009 Annual Report
Moscow, 29 April, 2010 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) issued Annual Report for the year 2009. Please use the following l...

185. Pharmstandard published the Audited Financial Results for the full year 2009 and results of sales for the 1st quarter of 2010
Moscow, April 29, 2010 – JSC Pharmstandard (LSE: PHST IL, RTS: PHST RU),  published the audited financial results for the year 2009 and non...

186. Pharmstandard to hold the AGM on 25 June 2010
Moscow, 5 May, 2010 – JSC Pharmstandard (LSE: PHST, RTS: PHST RU) invites its shareholders/holders to its annual general meeting of shareholders...

187. Results of Annual General Meeting
Moscow, 25 June, 2010 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces the results of its annual general meeting of shareholders ...

188. Notice of 1H2010 sales results announcement date
Moscow, 23 July, 2010 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 1H2009 sales results on Tuesday, 27...

189. OJSC PHARMSTANDARD ANNOUNCE UNAUDITED SALES RESULTS FOR THE FIRST 6 MONTHS OF 2010
Moscow, July 27, 2010 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU), announces its unaudited IFRS sales results for the first 6 months ...

190. Pharmstandard: Analyst & Investor Day


191. Agenda: Analyst & Investor Day
Pharmstandard (LSE: PHST LI, RTS: PHST RU), the leading Russian pharmaceutical producer, is pleased to invite the investment community to its Analyst&...

192. Notice of first half 2010 unaudited results announcement date
Moscow, 27 August 2010 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its unaudited results for the first half 2010 on...

193. Pharmstandard Reports Unaudited 1H2010 IFRS Results
Moscow, 1 September, 2010 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces its unaudited 1H2010 IFRS results. Net profit of the Compan...

194. JSC «Pharmstandard» reports about acquisition of 100% shares of the ZAO «Vindexpharm»
Moscow, 2 September 2010 – JSC «Pharmstandard» (LSE: PHST IL, RTS: PHST RU)  reports about acquisition of 100% shares of t...

195. Notice of 9M 2010 sales results announcement date
Moscow, 15 October 2010 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 9M 2010 sales results on Thursday, 28 ...

196. PHARMSTANDARD announces the results of sales for 9 months 2010
Moscow, 28 October 2010 – OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU), announces unaudited consolidated sales results according to IFRS for ...

197. OJSC Pharmstandard reports on closing transaction sales 11, 4% ordinary shares of the pharmaceutical company JSC «Grindex»
Moscow, 29 October 2010 – OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU), announces closing transaction sales of ordinary shares of pharmaceuti...

198. OJSC Pharmstandard-Leksredstva Announces Tender Offer for 4.9% of Pharmstandard Ordinary Shares
OJSC Pharmstandard-Leksredstva Announces Tender Offer for 4.9% of Pharmstandard Ordinary Shares  Moscow, 18 January, 2011 – OJSC Phar...

199. OJSC Pharmstandard announces the acquisition of 55% stake in PJSC "Biolek" (Ukraine)
           Moscow, 19 January 2011 – JSC Pharmstandard announces the acquisition of 55% stake in PJSC "Biolek" (Uk...

200. Notice of 2010 sales results announcement date
Moscow, 10 February, 2011 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 2010 sales results on Tuesday, 15 F...

201. Pharmstandard announces 2010 sales results
Moscow, 15 February 2011 – OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU, MICEX: PHST), announces unaudited consolidated IFRS-compliant sales r...

203. Pharmstandard Recognized as the Most Influential Pharmaceutical Manufacturer in Russia
According to the ranking by the leading pharma media Pharmaceutical Vestnik, Pharmstandard has been recognized as the most influential pharmaceutical ...

207. Pharmstandard OJSC announces senior management change.
Moscow, December 1, 2014 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the “Company”) annou...

208. Pharmstandard OJSC announces senior management change
Moscow, December 1, 2014 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU), the leading pharmaceutical company in Russia, announces today t...

209. The Board of Directors of the Open Joint-Stock Company “Pharmstandard” has approved the agenda of the annual shareholders’ meeting in relation to the progress of activities in 2014
The Board of Directors of the Open Joint-Stock Company “Pharmstandard” has approved the agenda of the annual shareholders’ meeting i...

210. Pharmstandard OJSC reports FY2014 Audited IFRS Results
Moscow, April 30, 2015 – Pharmstandard JSC (LSE:  PHST IL, RTS: PHST RU) (hereinafter referred to as Pharmstandard and/or the Company) anno...

213. JSC PHARMSTANDARD REPORTS 2008 AUDITED FINANCIAL RESULTS AND 1Q 2009 SALES RESULTS
Moscow, 28 April, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) published its audited 2008 financial results and sales results for 1Q 20...

214. NOTICE OF 2008 AUDITED FINANCIAL RESULTS AND 1Q 2009 SALES RESULTS ANNOUNCEMENT DATE
Moscow, 20 April 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 2008 audited Financial Results and 1Q 2009 Sa...

218. Pharmstandard OJSC announces the change in the number of own shares in its possession.
Moscow, October 01, 2014 - Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (hereinafter “Pharmstandard” or the “Company” annou...

219. Notice of 9M/Q3 2014 Sales Results – announcement date
Moscow, October 29, 2014 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 9M/Q3 2014  sales results on Th...

220. Pharmstandard OJSC reports its 9M/Q3 2014 sales results
Moscow, October 30, 2014 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or the “Company”) an...

221. Results of Board of Directors meeting
Moscow, 1 July, 2011 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces the results of its Board of Directors meeting held on June ...

222. Results of annual general meeting
Moscow, 1 July, 2011 — JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces the results of its annual general meeting of shar...

223. JSC Pharmstandard and DGM Group of Companies announce the establishment of Pharmstandard-Medtechnika LLC
Moscow, 5 July 2011. JSC Pharmstandard and DGM Group of Companies announce the establishment of Pharmstandard-Medtechnika LLC (Pharmstandard-Medtechni...

224. Notice of 1H2011 sales results announcement date
Moscow, 26 July, 2011 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 1H2011 sales results on Thursday, 28 July 2011 at ...

225. JSC Pharmstandard reports its 1H2011sales results
Moscow, 28 July 2011 – OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU) reports its non-audited sales results for 1H2011. Sales of Pharmstandard...

227. JSC PHARMSTANDARD ANNOUNCES FINANCIAL RESULTS FOR 2004, 2005 AND H1 2006
5 December 2006. Moscow – JSC PHARMSTANDARD announces its audited financial results for 2004 and 2005 and reviewed financial results for H1 2006...

228. JSC PHARMSTANDARD CONFIRMS INTENTION TO CONDUCT INITIAL GLOBAL SHARE OFFERING IN SECOND QUARTER OF 2007 AND ANNOUNCES 2006 RESULTS
11 April 2007, Moscow: JSC Pharmstandard (“Pharmstandard” or the “Company”), a leading domestic pharmaceutical company in Russ...

229. JSC PHARMSTANDARD ANNOUNCES US$11.55 TO US$14.55 PER GDR AND US$46.20 TO US$58.20 PER SHARE PRICE RANGE
23 April 2007, Moscow: JSC Pharmstandard (“Pharmstandard” or the “Company”), a leading domestic pharmaceutical company in Russ...

230. JSC PHARMSTANDARD ANNOUNCES PRICING OF THE OFFERING AT US$58.20 PER SHARE AND US$14.55 PER GDR
4 May 2007, Moscow: JSC Pharmstandard (“Pharmstandard” or the “Company”), a leading domestic pharmaceutical company in Russia,...

231. PHARMSTANDARD ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION FOLLOWING THE OFFERING OF ITS SHARES AND GDRS REPRESENTING SHARES
11 May 2007, Moscow: Further to the announcement dated 4 May 2007 in relation to the global offering (the “Offering”) of ordinary shares o...

232. PHARMSTANDARD CONDUCTED ANNUAL GENERAL MEETING
29 June 2007, Moscow. OJSC Pharmstandard, a leading domestic pharmaceutical company in Russia, today held its Annual General Shareholders Meeting ther...

233. Pharmstandard and Solvay Pharma announce signing of manufacturing Agreement
15 August 2007, Moscow. Solvay Pharma S.A.S., France, (“Solvay”), affiliate of Solvay Pharmaceuticals, and Pharmstandard-Tomskhimpharm JSC...

234. JSC PHARMSTANDARD ANNOUNCES H1 2007 REVIEWED RESULTS
Moscow, 18 September, 2007 – JSC Pharmstandard (“Pharmstandard” or the “Company”), the leading domestic pharmaceutical c...

235. Pharmstandard capitalization overturned $3 billion
October 4, 2007. OJSC Pharmstandard informs that yesterday Company GDRs traded at London Stock Exchange reached its historical maximum of $20 per...

236. Pharmstandard has been included in MSCI Index
Pharmstandard has been included in MSCI Index (with weight 0.47% in MSCI Russia and 0.04% in MSCI EM), changes will become effective as of the close N...

237. JSC PHARMSTANDARD ANNOUNCES 9 MONTHS 2007 SALES RESULTS
Moscow, 05 December, 2007 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces its unreviewed and unaudited sales results for the nin...

238. JSC PHARMSTANDARD AND JSC GRINDEKS ANNOUNCE SIGNING OF AGREEMENT
Moscow, 23 January, 2008 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) and JSC Grindeks, Latvia, announce signing of long-term collabora...

239. PHARMSTANDARD INVESTS INTO NEW PRODUCT AND R&D BASE
Moscow, 23 January, 2008 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces an acquisition of 19,88% shares of «DIPAKA TRAIDING L...

240. PHARMSTANDARD ANNOUNCES 2007 SALES RESULTS
Moscow, 14 February, 2008 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU), the leading domestic pharmaceutical company in Russia and the ...

241. JSC Pharmstandard today disclosed the completion of transactions
Moscow, 27 March, 2008 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU), the leading domestic pharmaceutical company in Russia and the third la...

242. JSC PHARMSTANDARD ANNOUNCES FCSM PERMISSION
OJSC PHARMSTANDARD ANNOUNCES FCSM PERMISSION  Moscow, 11 April, 2008 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU), the leading d...

243. JSC PHARMSTANDARD ANNOUNCES 2007 IFRS AUDITED RESULTS
Moscow, 14 April, 2008 – OJSC Pharmstandard (“Pharmstandard” or the “Company”), the leading domestic pharmaceutical comp...

244. JSC PHARMSTANDARD SALES IN Q1 2008 INCREASED 55%
Moscow, 12 May, 2008 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU), the leading domestic pharmaceutical company in Russia and the third...

245. JSC PHARMSTANDARD TO HOLD THE AGM ON 27 JUNE 2008
Moscow, 27 May, 2008 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU), the leading domestic pharmaceutical company in Russia and the third...

246. JSC PHARMSTANDARD ISSUED ANNUAL REPORT FOR THE YEAR 2007
Moscow, 30 June, 2008 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU), the leading domestic pharmaceutical company in Russia and the thir...

247. JSC PHARMSTANDARD ANNOUNCES UNAUDITED SALES RESULTS FOR THE FIRST 6 MONTHS 2008
Moscow, July 23, 2008 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU), the leading domestic pharmaceutical company in Russia and the thir...

248. NOTICE OF FIRST HALF 2008 UNAUDITED RESULTS ANNOUNCEMENT DATE
Moscow, 21 August, 2008 – OJSC Pharmstandard, the leading domestic pharmaceutical company in Russia and the third largest pharmaceutical co...

249. JSC PHARMSTANDARD ANNOUNCES THE ACQUISITION OF A NEW PRODUCT AFOBAZOL®
   Moscow, 27 August 2008 – OJSC “Pharmstandard” (LSE: PHST LI, RTS: PHST RU) today announced that it has agreed to ...

250. JSC PHARMSTANDARD REPORTS OUTSTANDING GROWTH IN 1H 2008
  OJSC PHARMSTANDARD REPORTS OUTSTANDING GROWTH IN 1H 2008 Moscow, 27 August, 2008 – Today OJSC Pharmstandard (“Pharmstandard&rdq...

252. OJSC Pharmstandard and Millhouse to Acquire Stakes in Biocad Holding Ltd.
Moscow, 22 May, 2014 – OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard”) and Millhouse LLC (“Millhouse&rd...

253. Pharmstandard OJSC announces AGM results
Moscow, June 27, 2014 – Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) announces the results of its annual general meeting of shareholders...

254. Merck and Pharmstandard announced collaboration on production of Rebif for MS treatment in Russia
Merck and “Pharmstandard OJSC” (further “Pharmstandard”) concluded a number of partnership agreements aimed at long-term colla...

255. OJSC Pharmstandard and Millhouse completed the Acquisition of Stakes in Biocad Holding Ltd.
Moscow, 24 July, 2014 – OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard”) and Millhouse LLC (“Millhouse&r...

256. The company “Augment” notified of the acquisition of Pharmstandard shares of stock from the company “Bristley”
Moscow, 14 May 2015 – Public Joint Stock Company “Pharmstandard” (LSE: PHST, RTS: PHST RU) (the “Company”) announced tha...

257. Pharmstandard OJSC reports its H1/Q2 2014 sales results
Moscow, August 14, 2014 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or the “Company”) ann...

258. Notice of H1 14 IFRS results(unaudited)
Notice of H1 14 Financial Results release date and conference call details  Moscow, August 26, 2014 – OJSC Pharmstandard (LSE: P...

259. Pharmstandard OJSC reports its H1 2014 financial results
Moscow, August 28, 2014 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or the “Company”) rel...

260. Pharmstandard announces temporary suspension of trading activities of ordinary shares on the Moscow Stock Exchange as of December 17, 2013.
Moscow, December 17, 2013 – Pharmstandard OJSC (“Pharmstandard” or the “Company”), a leading pharmaceutical company...

261. Pharmstandard announces registration of Sirturo® for MDR-TB
Moscow, December 19, 2013 — Russia’s leading pharmaceutical company Pharmstandard OJSC («Pharmstandard» or the ...

262. Pharmstandard completes reorganization.
Moscow, December 24, 2013 – Pharmstandard OJSC (“Pharmstandard” or the “Company”), a leading pharmaceutical company...

263. Notice of FY2013/4Q2013 sales results – announcement date
Moscow, February 18, 2014 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) (“Pharmstandard”) will be announcing its FY2013/4Q2...

264. FY2013/4Q2013 sales results
Pharmstandard OJSC reports FY2013/4Q2013 sales results Moscow, February 18, 2014 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further &ld...

265. Pharmstandard OJSC announces the record date for distribution of ordinary OTCPharm shares to its GDR holders.
Moscow, March 14, 2014 — Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further «Pharmstandard» or the «Company&ra...

266. Notice of FY2013 Audited Financial Results – announcement date
Moscow, April 22, 2014 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) (“Pharmstandard”) will be announcing its FY2013 Audite...

267. Pharmstandard OJSC reports FY2013 Audited IFRS Results
Moscow, April 25, 2013 –Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” and/or the ”Company”) reports i...

268. Pharmstandard OJSC Board of Directors approves agenda for Annual General Meeting of Share-holders.
Moscow, April 29, 2014 - Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (the “Company”) announced the results of its Board of Directors m...

269. Notice of 1Q14 Sales Results – announcement date
Moscow, May 16, 2014 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 1Q14 sales results on Tuesday, May ...

270. Pharmstandard OJSC reports 1Q14 Sales Results
Moscow, May 20, 2014 –Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) reports 1Q14 Sales Results.  In 1Q14, Pharmstandard sales reached RU...

271. Pharmstandard OJSC will buy out 1 436 920 ordinary shares from its shareholders.
Moscow, November 13, 2013 – Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) (the “Company” or “Pharmstandard”), Rus...

272. Pharmstandard filed an application for OTCPharm PJSC state registration.
Moscow, December 16, 2013 – Pharmstandard OJSC (“Pharmstandard” or the “Company”), a leading pharmaceutical company...

275. Pharmstandard reports its sales results for 3Q2012
Moscow, 25 October 2012– Pharmstandard OJSC (LSE: PHST IL, MICEX-RTS: PHST RU) reports its sales results for 3Q2012. Sales results:[i] &m...

276. Pharmstandard OJSC announces the Acquisition of a 100% stake in JSC “LEKKO”
Moscow, November 21, 2012 -O JSC Pharmstandard announces the acquisition of 100% stake in «LEKKO» CJSC. On September 6, 20...

277. Pharmstandard OJSC announces the signing of a partnership agreement with AVVA Rus OJSC.
Moscow, December, 11 2012 – Pharmstandard OJSC (LSE: PHST IL, MICEX-RTS: PHST RU), Russia’s leading pharmaceutical company, announces the ...

278. Pharmstandard OJSC announces that Pharmstandard-Ufavita OJSC and Pharmstandard-Leksredstva OJSC have joined the Association of Pharmaceutical Manufacturers of Eurasian Economic Community.
Moscow, December, 18 2012 — Pharmstandard OJSC (LSE: PHST IL, MICEX-RTS: PHST RU), Russia’s leading pharmaceutical company,...

279. Notice of Pharmstandard Full Year 2012 sales update announcement date
Moscow, February 12, 2013, – OJSC Pharmstandard (Pharmstandard JSC (LSE: PHST IL, MICEX\RTS (main):PHST, MICEX\RTS (classica):PHST) will be...

280. PHARMSTANDARD announces 2012 full year sales results.
Moscow, February 13, 2013 - OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU) announces unaudited consolidated sales results for 2012 in compliance with...

284. Notice of financial results for 1H2011 announcement date (unaudited)
Moscow, 23 August 2011 –Pharmstandard JSC (LSE: PHST LI, RTS: PHST RU) will be announcing its financial results for 1H2011 (unaudited) on Wednes...

285. Pharmstandard reports 1H2011financial results. (unaudited)
Moscow, 31 August, 2011 – OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU) reports 1H2011 unaudited financial results. Financial results and key...

290. Notice of 9M/3Q2013 sales results – announcement date
Moscow, October 21, 2013 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) (“Pharmstandard”) will be announcing its 9M/3Q 2013 ...

291. Pharmstandard OJSC reports 9M/3Q2013 sales results
Moscow, October 24, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or the “Company” ann...

295. Update re: Extraordinary General Shareholder’s Meeting of Pharmstandard OJSC. Voting.
Moscow, September 20, 2013 - Pharmstandard OJSC (the “Company”) announces additional details for voting at the Extraordinary General Share...

296. Pharmstandard OJSC: EGM results
Moscow, September 27, 2013 – Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) (the “Company” or “Pharmstandard” anno...

297. Pharmstandard OJSC informs of changes in the Investor Calendar
Moscow, August 30, 2013 -Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company») would li...

298. Pharmstandard OJSC announces changes in Shareholder Structure.
Moscow, September 06, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company&r...

299. Update re: Spin-off
Moscow, September 17, 2013 - Pharmstandard OJSC (the “Company”) announces that it is considering a spin-off of the Company’s branded...

300. Amgen to localize production of flagship antitumor drug in Russia
Source: Invest in Russia, 26.12.2017 US biotech major Amgen (Nasdaq: AMGN) has announced its plans to establish the production of its antitumor drug ...

301. Pharmstandard and Janssen Broaden Collaboration to Advance Ongoing Efforts to Tackle Multi-Drug-Resistant Tuberculosis
Pharmstandard JSC  and Janssen Pharmaceutica NV (part of the group of companies Janssen Pharmaceutical Companies holding Johnson & Johnson), ...

302. Pharmstandard Commits $30 Million to Argos Therapeutics Inc.
Moscow, August 27, 2013 – Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) (“Pharmstandard” or/and the “Company”) a...

303. Pharmstandard OJSC reports 1H 2013 Financial Results (unaudited)
Moscow, Аugust 28, 2013 –Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) reports 1H2013 unaudited Financial Results in compliance with IFRS.&nbs...

305. Pharmstandard OJSC announces EGM results
Moscow, August 19, 2013 – Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) announces the results of its extraordinary general meeting of sha...

306. Pharmstandard OJSC announces the closure of the transaction to acquire a stake in DONELLE COMPANY LIMITED
Moscow, August 22, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or the “Company” anno...

307. Pharmstandard OJSC announces the completion of the transaction to acquire Bever Pharmaceutical PTE Ltd (Singapore)
Moscow, August 22, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or the “Company” anno...

308. Notice of 1H2013 Financial Results (unaudited) – announcement date
Moscow , 26 August 2013 –Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) will be announcing its 1H2013 unaudited Financial Results on  ...

310. Pharmstandard OJSC announces the acquisition of a 10.87% stake in DONELLE COMPANY LIMITED.
Moscow, August 12, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard”) announces the acquisition of 10....

311. Pharmstandard OJSC agrees key terms of a potential acquisition of Bever Pharmaceutical PTE Ltd (Singapore)
Moscow, August 13, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the “Company”) announces k...

326. Notice of 1H 2013 sales results – announcement date
Moscow, 23 July 2013 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 1H 2013 Sales Results on Thursday, 25 July 2013 at...

330. Pharmstandard OJSC reports its 1H2013 sales results
Moscow, July 25, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or the “Company” announ...

332. Update on Pharmstandard buy-back program.
Moscow, July 16, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company») ann...

333. Update on Pharmstandard buy-back program.
HTML-редакторПеренос слов Moscow, July 17, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the...

336. Update on Pharmstandard buy-back program.
Moscow, July 12, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company») ann...

337. Update on Pharmstandard buy-back program.
Moscow, July 15, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company») ann...

339. Pharmstandard OJSC announces the extraordinary shareholder meeting in anticipation of a possible acquisition
Moscow, 8 July 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the “Company”) would like to i...

340. OJSC Pharmstandard announces the decision of the Board of Directors on the spin-off
Moscow, 8 July 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the “Company”) announces that ...

341. Notice of Pharmstandard Investor Conference Call details
Moscow, July 9, 2013, – OJSC Pharmstandard (Pharmstandard JSC (LSE: PHST IL, MICEX\RTS (main):PHST, MICEX\RTS (classica):PHST) will hold an...

342. Pharmstandard OJSC specifies details on a possible acquisition
Moscow, 9 July 2013 - Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the “Company”) would like to inform ...

343. Update on Pharmstandard buy-back program.
Moscow, July 11, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company»...

350. Update on Pharmstandard buy-back program.
Moscow, May 7, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company») ...

351. Pharmstandard OJSC announces the acquisition of a 41.93% stake in "Biolek" PJSC (Ukraine).
Moscow, May 28, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) announces the acquisition of 41.93% stake in "Biolek" PJSC (Ukraine) to r...

352. Pharmstandard OJSC announces the acquisition of a 41.93% stake in "Biolek" PJSC (Ukraine).
Moscow, May 28, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) announces the acquisition of 41.93% stake in "Biolek" PJSC (Ukraine) to r...

353. Pharmstandard OJSC announces AGM results
Moscow, May 28, 2013 — Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) announces the results of its annual general meeting of sha...

358. Notice of 9 months 2012 sales results announcement day
Moscow, 11 October, 2012 –Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) will be announcing its 9 months 2012 sales results on Thursday, 25 Oct...

359. Pharmstandard reports its sales results for 9M2012
Moscow, 25 October 2012– Pharmstandard OJSC (LSE: PHST IL, MICEX-RTS: PHST RU) reports its sales results for 9M2012. Sales results:[i] ·...

363. Pharmstandard OJSC Board of Directors approves agenda for Annual General Meeting of Shareholders.
Moscow, April 5, 2013 - Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (the “Company”) announced the results of its Board of Directors me...

364. Pharmstandard OJSC announces the Acquisition of a 100% stake in Pharmstandard International S.A.
Pharmstandard OJSC announces the Acquisition of a 100% stake in Pharmstandard International S.A.  Moscow, April 9, 2013 –Pharmstandar...

365. Pharmstandard OJSC reports 2012 audited Financial Results and 1Q2013 Sales Results
Pharmstandard OJSC reports 2012 audited Financial Results and 1Q 2013 Sales Results Moscow, April 29, 2013 –Pharmstandard OJSC (LSE: PHST IL, R...

367. Pharmstandard OJSC announces share buyback program
Moscow, February 15, 2013 – Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) Board of Directors approved a buyback program in respect of or...

368. Roche localizes the full cycle manufacturing of Gaziva® (obinutuzumab) at Pharmstandard-Ufa-VITA plant
 Roche localizes the full cycle manufacturing of Gaziva® (obinutuzumab) at Pharmstandard-Ufa-VITA plant  The project will be the first ...

369. Phs-Leksredstva JSC and the Kursk region Administration have signed a cooperation agreement
The other day the company was visited by Governor Alexander Mikhailov. General Director Evgeniy Prokhoda conducted a company tour for the head of the...

370. Pharmstandard, Rostec and Kedrion Biopharma Signed an Agreement to Establish JSC “Kirov Plasma”
National Immunobiological Company (“Nacimbio”), member of Rostec State Corporation, Pharmstandard PJSC and Italian biopharmaceutical compa...

371. Industrial Park for Small and Medium Enterprises to be established in Kursk Region
Industrial Park for Small and Medium Enterprises will be established  in Kursk Region Source: TASS Agency, 28.02.2017 14 entities have applie...

372. NOTICE OF 2008 SALES RESULTS ANNOUNCEMENT DATE
Moscow, 12 February, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 2008 sales results on Tuesday, ...

373. JSC PHARMSTANDARD REPORTS 2008 SALES RESULTS
Moscow, 17 February, 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces its unaudited 2008 sales results. The total reven...

374. Pharma Manufacturers Come Forward with the Initiative of Pilot Pharmaceutical Registration in EAEU
Source: Pharmaceutical Vestnik, February, 03, 2017 The pharma manufacturers, Pharmstandard, Rozleks Farm, Gedeon Richter, as well as representatives...

375. In 2016 Russia imported 11.4 thousand tons of pharmaceutical substances
Source: GMP News, 01.02.2017 In 2016, 11.4 thd. tons of active pharmaceutical ingredients (API) were imported into Russia for a total of 59.3 billio...

376. JSC PHARMSTANDARD COMPLETED NEXT MODERNIZATION STEP
29 November 2006. Kursk. Pharmstandard announces today that OJSC Pharmstandard-Leksredstva in Kursk has launched three new production lines. This laun...

377. Pharmstandard is the most influential Russian pharmaceutical company of 2017
March 26, 2018 PharmVestnik announced the results of the annual Rating of the Most Influential Pharmaceutical Market Entities, based on the results o...

378. On March 15, 2018 the shareholders of Pharmstandard JSC decided to reorganize the Company
March 27, 2018 At the extraordinary general meeting of the Pharmstandard JSC shareholders, taking place on the 15th of March, 2018, it was decided to...

379. квартальные отчеты


380. календарь инвестора


381. JSC PHARMSTANDARD REPORTS UNAUDITED SALES RESULTS FOR THE NINE MONTHS OF 2008
  Moscow, 15 October, 2008 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces its unaudited IFRS sales results for the nine-...

382. JSC PHARMSTANDARD OBTAINED EU GMP CERTIFICATIONS
Moscow, 20 January 2009 – JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces European Union Good Manufacturing Practice (EU GMP) cert...

383. Pharmstandard wins the All-Russian open competition "Platinum Ounce-2016"
According to the results of the 17th annual industry competition “Platinum Ounce-2016”, Pharmstandard is one of the leaders in nomination ...

384. Pharmstandard wins the BEST.RU 2016 award
On April 24, 2017, the solemn ceremony marked the winners of the business award “The Best in Russia – 2016/Companies, Persons, Projects of...

385. Pharmstandard has changed its legal form
On May 22, 2017, the amended Charter was registered. Public Joint Stock Company “Pharmstandard” has become Joint Stock Company “Phar...

386. Best in Pharma
Source: Rossiyskaya Gazeta, 29.03.2017 On March 28, the press conference on launching the III International Pharmaceutical Award “Green Cross&r...

423. Pharmstandard has approved a possible purchase of additional ordinary shares by its subsidiary.
Moscow, 30 August 2012 — OJSC Pharmstandard (LSE: PHST LI, MICEX-RTS: PHST RU) has approved a possible purchase of additional ord...

424. Pharmstandard has approved a possible purchase of ordinary shares by its subsidiary in the amount of up to RUR 1.1 billion.
Moscow, 9 June 2012 — OJSC Pharmstandard (LSE: PHST LI, MICEX-RTS: PHST RU) has approved a possible purchase of ordinary shares o...

425. OJSC Pharmstandard announces the purchase of ordinary shares of the holding Company by its subsidiary OJSC Pharmstandard-Leksredstva.
Moscow, 20 June, 2012. OJSC Pharmstandard (LSE: PHST LI, MICEX-RTS: PHST RU) announces the purchase of ordinary shares of the holding Compan...

426. OJSC Pharmstandard announces the acquisition of 50.1% stake in Bigpearl Trading Limited.
Moscow, 26 June 2012 – JSC Pharmstandard announces the acquisition of 50.1% stake in BIGPEARL TRADING LIMITED (Cyprus). In February,2012 Russia...

427. The increase of Pharmstandard’s share in the Rx segment
On June 26, 2012, OJSC Pharmstandard announced the purchase of a controlling stake in Bigpearl Trading Limited (Cyprus). This acquisition of a control...

428. Notice of 1H2012 sales results announcement date
Moscow, 19 July, 2012 — JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 1H2012 sales results on Thursday, 2...

429. OJSC Pharmstandard reports its 1H2012 sales results
Moscow, 26 July – OJSC Pharmstandard (LSE: PHST IL, MICEX-RTS: PHST RU) reports its non-audited results for 1H2012. 1H2012 Key Highlights: &mi...

430. Pharmstandard is pleased to invite to its Analyst & Investor Day (September 13, 2012)
Analyst & Investor Day Pharmstandard OJSC (LSE: PHST IL, MICEX-RTS: PHST RU), the leading Russian pharmaceutical producer, is pleased to invite th...

431. Notice of financial results 1H2012 IFRS announcement day
Moscow, 10 August 2012 –Pharmstandard OJSC (LSE: PHST IL, MICEX-RTS: PHST RU), will be announcing its financial results for 1H2012 (unaudit...

432. Pharmstandard reports 1H2012financial results
Moscow, 29 August, 2012 – OJSC Pharmstandard (LSE: PHST IL, MICEX-RTS: PHST RU) reports 1H2012 unaudited financial results. 1H2012 Key Highligh...

496. Pharmstandard announces sales results for 2011.
Moscow, 10 February, 2012 – Pharmstandard JSC (LSE: PHST IL, MICEX\RTS (main):PHST, MICEX\RTS (classica): PHST ) announces unaudited consolidate...

516. Pharmstandard: Analyst & Investor Day 2011
Pharmstandard (LSE: PHST LI, RTS: PHST RU), the leading Russian pharmaceutical producer, is pleased to invite the investment community to&nb...

517. Notice of 9M 2011 sales results announcement date.
28 October 2011 — JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 9M 2011 sales results. Pharmstandard is ...

518. Notice of 2011 sales results announcement date
Moscow, 7 February, 2012 — OJSC Pharmstandard (Pharmstandard JSC (LSE: PHST IL, MICEX\RTS (main):PHST, MICEX\RTS (classica):PHST) will be&n...

519. PHARMSTANDARD announces the results of sales for 9M2011.
Moscow, 28 October 2011 – OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU) announces unaudited consolidated sales results according to IFRS for 9...

663. Dmitry Medvedev visited the Biotechnology Centre Generium.
Dmitry Medvedev, while on a working trip to Vladimir Region, visited the Biotechnology Centre Generium which has received a Skolko...

694. Amgen and Pharmstandard announce manufacturing and commercialization agreement for Russian market
Moscow. (Dec. 19, 2017) — Amgen (NASDAQ: AMGN) and Pharmstandard announced that the parties have entered into an agreement for the manufacture a...

695. Results of Annual General Meeting
Moscow, 25 May, 2012 — JSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) announces the results of its annual general meeting of shar...

794. Pharmstandard PJSC shares to be delisted as of March 24
Pharmstandard PJSC plans to delist from the Moscow Exchange.  The announcement on delisting of the issuer’s equity securities not to be ...

795. Pharmstandard announces the receipt of notification on expiration of mandatory tender offer
Moscow, September 14, 2016 PJSC Pharmstandard (LSE: PHST IL, МОЕХ: PHST RU) (hereinafter the "Company" or "Pharmstandard") announces the receipt of n...

796. The Ministry of Health of the Russian Federation Has Expressed Concern over Patent Protection of Medicinal Products
The Ministry of Health of the Russian Federation has declared the auctions on state procurement of Lenalidomide as void due to lack of documents confi...

797. Pharmstandard announces the receipt of notification on expiration of mandatory tender offer
Pharmstandard announces the receipt of notification on expiration of mandatory tender offer Moscow, September 02, 2016 PJSC Pharmstandard (LSE: PHST...

798. Pharmstandard and Ferring announce collaboration to localize full-cycle manufacturing of innovative obstetrical and gynaecological pharmaceuticals in Russia
Moscow, August 26, 2016 - Global biopharmaceutical company Ferring Pharmaceuticals and Pharmstandard JSC, Russia’s leading pharmaceutical c...

799. Board of Directors approved recommendations in respect of the Mandatory tender offer and approved amendments to the Deposit Agreement
PJSC PHARMSTANDARD (LSE: PHST IL, МОЕХ: PHST RU) ANNOUNCES APPROVAL BY THE COMPANY’S BOARD OF DIRECTORS OF RECOMMENDATIONS IN RESPECT OF THEMA...

800. The Company received Mandatory Tender Offer to acquire ordinary shares
Moscow, June 22, 2016PJSC Pharmstandard (LSE: PHST IL, МОЕХ: PHST RU) (hereinafter the “Company” or “Pharmstandard”) anno...

801. Pharmstandard reports FY2015 Audited IFRS Results
Moscow, April 29, 2016 – Pharmstandard PJSC (LSE:  PHST IL, RTS: PHST RU) (hereinafter referred to as Pharmstandard and/or the Company) ann...

802. Pharmstandard-Leksredstva plans to launch new lines worth RUB 1.9 billon
Pharmstandard is set to launch two new production lines worth RUB 1.9 billion at the factory of Pharmstandard-Leksredstva OJSC in the third quarter of...

803. Pharmstandard was invited to take part in the tender for long-term supplies of pharmaceuticals in Karelia
Source: PharmVestnik, May 3, 2018. In May 2018, the management of Pharmstandard JSC is to take a decision on a factory construction in Karelia, wrote...

804. Imports of active pharmaceutical ingredients (AFI) to Russia based on the 2017 year-end results
Source: PharmVestnik, 27.04.2018 According to last year’s results, the volume of AFI supplies to Russia reached a historic high, both in moneta...

805. Pharmstandard and Viriom announce their intention to cooperate in manufacturing of innovative anti-HIV pharmaceutical product
Pharmstandard JSC, one of Russia’s leading pharmaceutical companies, and Viriom Ltd., the company developing innovative pharmaceutical products,...

806. Gilead and Pharmstandard Announce New Manufacturing Agreement to Expand Access to Medicines for Patients in Russia
Gilead Sciences, Inc. (NASDAQ: GILD) and Pharmstandard today announced that they have entered into an agreement that grants Pharmstandard rights to ...

807. Takeda has Produced the First Batch of an Innovative Oncohematological Drug for Patients with Hodgkin's Lymphoma at the Pharmstandard-UfaVITA Plant
Takeda LLC (Takeda Russia) and Pharmstandard JSC announced the release of the first batch of brentuximab vedotin, trading as ADCETRIS®, an innovat...

808. Phs-Leksredstva JSC will become the main manufacturer of medicines for treating asthma in Russia
A new unit for manufacturing import-substituting asthmatic medicines (pulmo powder) was officially opened at Kursk factory. The total project cost equ...

809. RF Government Prize for Quality has been awarded to Pharmstandard- Leksredstva JSC
10 November Prime Minister Dmitry Medvedev has signed a Decree “On awarding the RF Government Prizes in the field of quality”. The docume...

810. Shortening of the Code for Drugs Labeling to Speed Up the System Implementation in the Russian Federation – Center for the Development of Advanced Technologies
Simplification of the printing technology of the drug labeling code, including its length shortening may speed up implementation of the drug labeling ...

811. Pharmstandard-Leksredstva Wins the Government Award
Russian Prime Minister Dmitry Medvedev handed over the awards for excellence in quality management to the country’s best companies. According t...

812. Pharmstandard Becomes One of the Prize Winners in National Pharmaceutical Rating 2018
The Annual Awards Ceremony was held in the Leningrad Club. On December 18, the Annual Awards Ceremony for the National Pharmaceutical Rating winners ...

813. Grigory Potapov, CEO, Pharmstandard JSC, on Drug Labeling
“Manufacturers would like to have a more self-explanatory regulation mechanism.” According to Kommersant, on December 17, 2018, Russian P...

814. Pharmstandard Named The Most Influential Russian Pharmaceutical Manufacturer Once Again
Pharmstandard has preserved its leadership in Rating of the Most Influential Subjects of the Russian Pharmaceutical Market, 2018 According to PharmVe...

815. Biomed of Krasnogorsky District: A Hundred Years of History and A Modern Production
As part of a series of business trips to district enterprises, Elmira Khaimurzina, Head of the Krasnogorsky District, visited J.S.C. “Biomed&rdq...

816. Pharmstandard Intends To Invest RUB 2.5 Billion In The Ufa Plant
On February 14, during the Russian Investment Forum in Sochi, Radiy Khabirov Acting Head of the Republic of Bashkortostan, and Viktor Kharitonin, Exec...

817. Viriom and Pharmstandard Team Up To Fight HIV
Pharmstandard, the leader of the Russian pharmaceutical market, and ChemRar Group, the leading developer of medical products, have combined their effo...

818. Pharmstandard-Leksredstva Launches 15 New Medicinal Products in 2019
Photo from the official website of the Kursk Region Administration Roman Starovoyt, Acting Governor of the Kursk Region, and Evgeny Prokhoda, Directo...

819. Industry of the Kursk Region Works Steadily and Develops
During the press-conference held at the Kursk House of Journalists on March 20, 2019, Roman Kolesnichenko, Chairman of the Committee on Industry and T...

820. Following Q1 2019 Pharmstandard Demonstrates an Increase in Shipment
According to RNC Pharma http://rncph.ru/news/24_04_2019, following the results of Q1 2019 Russia’s output of pharmaceuticals totaled to RUB ...

821. Good Practices Uniting the Industry and the World
The flagship conference dedicated to good practices in pharmaceutical production, IV All-Russian GMP Conference with international participation, will...

822. OJSC Pharmstandard-Leksredstva Plans to Draw $7m for Modernization in 2019
Source: GMP News, 15.05.2019 OJSC Pharmstandard-Leksredstva, Pharmstandard’s structure based in Kursk, plans to draw 500 million rubles in 2019...

823. Reliable partner twice as strong now
Rossiyskaya Gazeta, Special Issue No 120(7878) CEO of Pharmstandard JSC joined the debate on the pages of Rossiyskaya Gazeta. The discussion cen...

828. Gilead Sciences Announced the Expansion of Partnership with Pharmstandard on Localization of Production in Russia
Moscow, September 4, 2019. Pharmaceutical company Gilead Sciences has announced the expansion of its partnership with Pharmstandard covering a...

829. Pharmstandard and Bristol-Myers Squibb (BMS) have concluded an agreement to transfer the rights to Daklinza for the treatment of Chronic Hepatitis C
Pharmstandard JSC and Bristol-Myers Squibb (BMS) have signed agreements to transfer the rights to manufacture, sell and distribute medicinal pro...

830. Pharmstandard ranked among the leaders of “National Pharmaceutical Rating”
On January 29, Moscow hosted the award ceremony for the winners of “National Pharmaceutical Rating”. Pharmstandard ranked  among the ...

831. Pharmstandard-UfaVITA shall manufacture solutions in polymer package
Currently, Pharmstandard-UfaVITA JSC is implementing three priority investment projects of the Republic. One of the projects is “Manufacturing o...

832. One of Pharmstandard products earned an award of Russian Pharma Awards®
The 8th annual Russian Pharma Awards® ceremony was held in Moscow. Russian Pharma Awards® is a unique award for Russia, which annually picks ...

833. Pharmstandard announces the price reduction for antiviral medicinal product Daklinza in Russia
Pharmstandard JSC declares the reduction in the maximum selling price for medicinal product Daklinza®(daclatasvir), film-coated tablets, 60 mg. Th...

834. Pharmstandard Transferred Critical SAP Business Systems to Croc Data Centre
Pharmstandard, a Russian pharmaceutical manufacturer, will place its critical SAP business systems in the Croc Cloud Services data centre. The ERP sys...

835. Pharmstandard Digital Ecosystem Project Gets Platinum Ounce
On 4 June, an award ceremony was held as part of the Platinum Ounce 2019 contest. According to the Contest Expert Committee, the Medicine360 project w...

836. Marking of Medicines is of Great Importance for the Whole Country
Pharmstandard CEO discusses the benefits of digitalisation     From 1 July 2020, the law on the mandatory use of digital codes to mar...

837. The Future of Healthcare: Budget Balance
By Strategiya magazine. February 2020. Summing up the 9th Gaidar Forum sponsored by the Pharmstandard company: "healthcare efficiency" was one of the...

838. LifeScan Completes Localisation of Test Strip Production in Russia
Source: GMP News, 31 March 2020 LifeScan, specialising in the production of blood glucose monitoring systems and digital diabetes management solution...

839. Pharmstandard-Leksredstva will Upgrade Its Production Facilities
The modernisation of production facilities was discussed on 17 June at a meeting of the Executive Director of Pharmstandard JSC Viktor Kharitonin and ...

840. Gilead Sciences and Pharmstandard Signed a Memorandum of Understanding for the Localization and Distribution of Veklury™ (remdesivir*) in Russia
— Gilead has applied to the Ministry of Health of Russia for approval for its COVID-19 therapy in the Russian Federation — Moscow, Septem...

841. Pharmstandard-Leksredstva JSC made it to the List of the Most Profitable Pharmaceutical Manufacturers in the Russian Market
Source: RBC 2019 witnessed a considerable growth of pharmaceutical production volume in Russia (by 24.5% in financial terms, reaching 386.7 bln ...

842. For Patients in Russia. Pfizer localizes the Manufacturing of Innovative Cancer Medicinal Products in Russia in Partnership with Pharmstandard
Pfizer and Pharmstandard have signed an agreement on contract manufacturing in the territory of the Russian Federation (at Pharmstandard-UfaVITA plant...

843. Pharmstandard recognized as the most influential domestic pharmaceutical manufacturer in 2020
The information and analytical newspaper Pharmvestnik  has announced the results of its annual Rating of the Most Influential Pharmaceutical Mark...

844. Generium to raise its annual output of anti-COVID-19 vaccine up to 200-300 million doses
Finanz.ru Generium plans to bring its anti-COVID-19 vaccine production up to 200-300 million doses annually, announced Pharmstandard Chairman of the ...

845. “Supplier to the Government of Moscow” title conferred on 24 companies in 2020
Glas Naroda Honorary diplomas were conferred on the award winners at the Goszakaz (Government Procurement) expo forum on 25 March. The title &ldquo...

846. Rating of doctors' confidence in pharmaceutical manufacturers
GxP News Across the globe, many governments gave their citizens the heads-up for the imminent start of  vaccination against COVID in November. M...

847. Pharmstandard-UfaVITA CEO Receives the ‘For Merit to the Fatherland’ Medal (II Class)
V. A. Kreyman, CEO of Pharmstandard-UfaVITA OJSC, has received a top-tier government award for his professional achievements and many years ...

848. Phosphogliv URSO Receives Platinum Ounce 2020 Award
The brand has won the award's special nomination for an innovative approach to treating biliary pathology. The winners of the 21st Platinum Ounce com...

849. Exclusive: TV program Vesti Visits to the Ufa Plant Where Sputnik V Vaccines Are Bottled and Packaged
Bashkortostan State TV and Radio Broadcasting Company, 20 April 2021  The Republic of Bashkortostan has received another batch of coronavirus va...

850. OJSC Pharmstandard-UfaVITA Statement on Preliminary Questions of WHO Inspection
UfaVITA Filling Company Statement on Preliminary Questions of WHO Inspection at One of its Filling Lines: UfaVITA is only responsible for filling t...

851. Pharmstandard-UfaVITA: Investments in the Modernisation of Production
The production index of Pharmstandard-UfaVITA OJSC for the first seven months of this year exceeded 180%.             &...

852. Russian Company Ranks Among the Top Three in the Pharmaceutical Market
Pharmvestnik, 22 August 2021 Since 2014, the pharmaceutical market has grown by 85% in value and reached 1.8 trillion roubles in 2020. In physical te...

853. Pharmstandard-UfaVITA JSC will take part in a pilot project of the Ministry of Labour and Social Protection of the Russian Federation
The Republic of Bashkortostan will be included in the list of regions participating in the Project for Improving OHS Risk Assessment and Management. T...

854. Market-leading companies signed an agreement to establish the National ESG Alliance
Teleinform News Agency, 2 December 2021 The conference dedicated to the establishment of the National ESG Alliance was attended by senior executives ...

855. Pharmstandard Chief Executive Officer attends industry development meeting
Sergey Sobyanin, the Mayor of Moscow held a meeting with the representatives of major pharmaceutical companies. The topics of discussion included indu...

856. Pharmstandard JSC and Johnson & Johnson LLC signed a memorandum on cooperation
Johnson & Johnson and Pharmstandard have announced the signing of a memorandum on cooperation in the field of the innovations for d...

857. AbbVie and Pharmstandard announced the start of the localization of Sinagis® in Russia. The product is used to prevent respiratory syncytial virus infection in children
Moscow, 30 June 2015 The global biopharmaceutical company AbbVie and the largest pharmaceutical manufacturer in Russia [1] Pharmstandard JS...

858. From a candle factory to Pharmstandard: Kursk plant turns 100
The Kursk pharmaceutical plant, Phs-Leksredstva JSC celebrates its centenary this year. The facility was established on the basis of a candle factory ...

859. Pharmstandard recognised as Platinum Ounce Manufacturer of the Year
The Platinum Ounce XXII All-Russian Competition for Pharmaceutical Professionals took place in Moscow on 14 April. The event traditionally brought to...

860. Pharmstandard wins Smartpharma® Awards 2022
Annual Smartpharma® Awards 2022 ceremony was held in Moscow. Smartpharma® is the only Russian award where winners are selected exclusively by ...

861. Russia may start tracking the origin of active ingredients
PharmMedProm, September 19, 2022 It is suggested that Russian pharmaceutical manufacturers implement a system for tracking the origin of active pharm...

862. 'It's time to commit to the cause,' says Vladimir Kreiman
Vladimir Kreiman, General Director of Pharmstandard-Leksredstva, gave an interview to Pharmvestnik, where he spoke about the prospect of rapid import ...

863. Pharma companies do not expect shortages of medicines due to abandonment of European packaging
TASS, 13 April 2022  Domestic pharmaceutical companies are continuing production as usual and are not experiencing difficulties with switching t...

864. “20,000 deaths per year from a completely treatable disease”: how to identify and treat hepatitis C patients
Social Information Agency, July 5, 2022 What are the issues that patients face, and what do the Ministry of Health and other experts recommend? On J...

865. Pharmstandard will construct a new production facility in Ufa
The investment project will be implemented in 2023–2025. The total amount of investment is estimated to be 2.6 billion rubles. According to N...

866. Pharmstandard Receives the Title "Supplier to the Government of Moscow"
The title "Supplier to the Government of Moscow” confirms that the company is a reliable and conscientious partner that helps to implement impor...

867. Pharmstandard Releases the First Lot of Labeled Nutritional Supplements
Pharmstandard Group has released the first lot of labeled nutritional supplements – Asvitol®Sun chewable tablets in a pack. The special Data...

868. Pharmstandard-UfaVITA JSC launched the manufacturing of blood coagulation products
On December 24, Denis Manturov, Deputy Prime Minister of the Russian Federation - Minister of Industry and Trade of the Russian Federation, and Radiy ...

869. Pharmstandard Is Russia’s Most Influential Pharmaceutical Company 2022
14.03.2023  Bionika Media and Pharmvestnik have published the results of their annual Influence Ranking of the Russian pharmaceutical market pla...

870. LEKKO CJSC Celebrated 30th Anniversary
Festive events dedicated to this remarkable date were held in the Culture Hall of Volginsky settlement. The regional administration and the delegates ...

871. Pharmstandard Awarded in Flying High Nomination
01.03.2023 Awarding of the winners in the Flying High nomination was held in Dolgoprudny. The competition was established on the initiative of Vladis...

872. Dmitry Zaytsev has been named Chief Executive Officer of JSC “Pharmstandard”
JSC “Pharmstandard” informs about the change to the membership of the Company's management and the appointment of Dmitry Ivanovich Zaytsev...

873. Chief Operating Officer of JSC “Pharmstandard” was awarded a medal of the Order of Merit for the Fatherland, II degree
The excellence award was presented on May 31 at an extended meeting of the Collegium of the Ministry of Industry and Trade of the Russian Federation. ...

874. About the Pharma-2030 Strategy
The Board Members of the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union (APMEEU) shared their comments on the industry dev...

875. SPIEF: Drug Safety
Dmitry Zaytsev, CEO of JSC “Pharmstandard”, believes that the past year was tough for the industry, but thanks to a package of anti-crisis...

876. Pharmstandard takes the lead in the EEG rating
The EEG rating is a large-scale Russian project aimed at assessing companies that use responsible business practices. According to the Kommersant news...

877. Students are the human resources potential of Pharmstandard
Ufa University of Science and Technology and Pharmstandard — UfaVITA have signed a cooperation agreement. The mutually beneficial partnership wi...

878. Pharmstandard has partnered with the Kursk branch of the Finance University under the Government of the Russian Federation
Photo source: The Kursk branch of the Finance University under the Government of the Russian Federation On 5 December, 2023, the parties signed an ...

879. PHARMSTANDARD'S and KAMA's exposition recognised as the best at Pharmtech & Ingredients 2023
The booth shared by Pharmstandard and Kama received the title of the BEST RUSSIAN EXPOSITION at Pharmtech & Ingredients 2023, the 25th Anniversa...

880. New facility making tablets and soft gelatine capsules to open in Kursk
PharmMedProm, 31 May 2023 Phs-Leksredstva will launch a new shop for the production of solid dosage forms. It will also start making gelatine ca...

881. Bashkiria will see new pharmaceutical investment projects
BezFormata, 6 June 2023 The head of Bashkiria has thanked Pharmstandard Holding for effective cooperation with the republic and boosting the healthca...

882. DSM calculates sales of antipyretics, analgesics, and NSAIDs in the first half of 2023
Russian Association of Pharmacy Networks, 20 September 2023 DSM Group has analysed the market of anti-inflammatory, antipyretic, and analgesic drugs ...

883. Pharmstandard to provide Lab Industries with expert support on labelling issues
The Ministry of Industry and Trade of the Russian Federation proposes to conduct an experiment in Russia on the labelling of household chemicals and...

884. Pharmstandard has reached full capacity for manufacturing Plasma-Derived Coagulation Factor VIII for Haemophilia A treatment
JSC “Pharmstandard” has registered a domestic Plasma-Derived Coagulation Factor VIII for the treatment of Haemophilia A under trademark &l...

885. Pharmstandard will launch somatropin supplies to Circle of Kindness in April
Somatropin is to be purchased for the Circle of Kindness for the first time. In October 2023, Circle of Kindness added Turner syndrome to the list of ...

886. Pharmstandard-UfaVITA JSC launches the supplies of Russian plasma blood coagulation factor VIII
At the end of 2023, Pharmstandard-UfaVITA JSC (Ufa) reached full production of the Plasma-Derived Coagulation Factor VIII under trademark Eightop...

887. Production of essential plasma-derived medicines to be established in Moscow
Photo by M. Mishin. Press Office of the Mayor and Government of Moscow At the 27th St Petersburg International Economic Forum, Sergei Sobyanin, Mos...

888. Pharmstandard-UfaVITA Invests RUB 10.4 BLN in the Manufacturing and Warehouse Facility, as well as the Reconstruction of One of its Workshops in Ufa.
RBC, 08.07.2024 On the sidelines of Innoprom 2024, Nail Nizamutdinov, General Director of the Company, and Andrey Nazarov, Prime Minister of Bashko...

889. Pharmstandard to Build a New Production and Office Building in Ufa
Image: Public Affairs Office of the Government of Bashkortostan  Pharmstandard-UfaVITA JSC and the Government of Bashkortostan plan to impleme...

890. SPIEF-2024 Business Programme: “Ensuring Drug Security” Forum
Dmitry Zaitsev, JSC Pharmstandard CEO, takes part in the “Ensuring Drug Security” Forum. On the day “zero” of SPIEF-2024, the ...

891. Dmitry Zaitsev spoke about large-scale production expansion
Pharmstandard is celebrating its 20th anniversary this year. Dmitry Zaitsev, Pharmstandard JSC CEO, told Regnum News Agency in an interview about what...

892. Pharmstandard laboratory started its work in the KidZania Park of Professions in Moscow
On September 21, a grand opening ceremony for KidZania Park’s new location in Moscow’s Aviapark shopping centre took place. Now, all young...

893. Dmitry Zaitsev: “Russian pharma consists of world-class companies”
RBC-Ufa, RBC-UFA Open Studio: All-Russian GMP-conference, August 27, 2024 Dmitry Zaitsev, Pharmstandard JSC CEO Interview with Pharmstandard ...

894. Pharmstandard Team awarded with the Employer of the Future 2025 Prize
The Employer of the Future 2025 Prize award ceremony took place on 25 March. The annual national award in the field of HR in the pharmaceutical indu...

895. The Pharmstandard Brand Zone Opened at UUNiT
Pharmstandard made the educational process at the Ufa University of Science and Technology (UUNiT) more comfortable for students. A Pharmstandard bran...

896. Pharmstandard Preserves Its Status as the Leader of the ECG Rating
Pharmstandard JSC has once again received the highest level (AAA) of the National Standard for Sustainable Business, the EKG Rating. The rating develo...

897. PHARMSTANDARD Entered the TOP-100 of the Best Employers
HeadHunter has published its annual Employer Rating. It is being compiled already for 15 years. According to hh.ru, in 2024, 1,729 companies from 72...

898. Pharmstandard launched Eutoplasm clinical trial in children
First paediatric patients with severe haemophilia A started to receive treatment with Eutoplasm (blood clotting factor VIII) as part of an internation...